A Study of RO5028442 in Adult Male High-Functioning Autistic Patients

NCT01474278 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Autistic Disorder

Interventions

DRUG: Placebo
DRUG: RO5028442

Sponsor

Hoffmann-La Roche